$BCBP
BCB BANCORP INC

2022 Q4 Form 10-Q Financial Statement

#000122845422000034 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $34.40M
YoY Change 22.23%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $511.0K $493.0K
YoY Change -36.13% -45.22%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $3.449M
YoY Change -2.32%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $15.71M $18.94M
YoY Change 4.43% 61.61%
Income Tax $3.634M $5.552M
% Of Pretax Income 23.14% 29.31%
Net Earnings $11.90M $13.39M
YoY Change 10.7% 60.92%
Net Earnings / Revenue 38.93%
Basic Earnings Per Share $0.78
Diluted Earnings Per Share $688.3K $771.6K
COMMON SHARES
Basic Shares Outstanding 16.89M 16.98M
Diluted Shares Outstanding 17.36M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $229.4M $221.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $24.03M $22.51M
YoY Change 96.36% 73.17%
Goodwill $5.200M $5.200M
YoY Change -1.89%
Intangibles
YoY Change
Long-Term Investments $17.69M $18.41M
YoY Change -29.78% -21.78%
Other Assets $16.46M $15.86M
YoY Change 26.63% 17.5%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.546B $3.266B
YoY Change 19.5% 9.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $13.86M $12.10M
YoY Change 8.27% -10.36%
Deferred Revenue
YoY Change
Short-Term Debt $60.00M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.86M $12.10M
YoY Change 8.27% -10.36%
LONG-TERM LIABILITIES
Long-Term Debt $37.51M $37.45M
YoY Change 0.56% 0.67%
Other Long-Term Liabilities $9.704M $8.309M
YoY Change -6.69% -16.91%
Total Long-Term Liabilities $47.21M $45.76M
YoY Change -1.02% -3.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.86M $12.10M
Total Long-Term Liabilities $47.21M $45.76M
Total Liabilities $3.255B $2.983B
YoY Change 20.84% 9.64%
SHAREHOLDERS EQUITY
Retained Earnings $115.1M $105.9M
YoY Change 41.81% 44.29%
Common Stock $196.2M $195.1M
YoY Change 1.15% 0.75%
Preferred Stock $21.00M $21.00M
YoY Change -27.38% -18.35%
Treasury Stock (at cost) $34.53M $33.12M
YoY Change 10.94% 12.55%
Treasury Stock Shares $2.967M $2.885M
Shareholders Equity $291.3M $282.7M
YoY Change
Total Liabilities & Shareholders Equity $3.546B $3.266B
YoY Change 19.5% 9.45%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $11.90M $13.39M
YoY Change 10.7% 60.92%
Depreciation, Depletion And Amortization $511.0K $493.0K
YoY Change -36.13% -45.22%
Cash From Operating Activities $8.128M $13.02M
YoY Change -36.5% 10.31%
INVESTING ACTIVITIES
Capital Expenditures $297.0K -$140.0K
YoY Change 40.0%
Acquisitions
YoY Change
Other Investing Activities -$264.3M -$181.5M
YoY Change 1572.94% -960.09%
Cash From Investing Activities -$264.6M -$181.6M
YoY Change 1564.29% -964.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 264.8M 183.5M
YoY Change -1039.11% 124.0%
NET CHANGE
Cash From Operating Activities 8.128M 13.02M
Cash From Investing Activities -264.6M -181.6M
Cash From Financing Activities 264.8M 183.5M
Net Change In Cash 8.335M 14.85M
YoY Change -126.63% -87.05%
FREE CASH FLOW
Cash From Operating Activities $8.128M $13.02M
Capital Expenditures $297.0K -$140.0K
Free Cash Flow $7.831M $13.16M
YoY Change -38.82% 10.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Expired Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExpiredExercisePriceRange
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRange
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
CY2022Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-50275
dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
823-0700
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
BCBP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16891520
CY2022Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11192000
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9606000
CY2022Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
209832000
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
402023000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221024000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2022Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2021Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
92751000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
18408000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
25187000
CY2021Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
952000
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
33195000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
37119000
CY2022Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2787015000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2304942000
CY2022Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
12388000
CY2021Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6084000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10723000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12237000
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5431000
CY2022Q3 us-gaap Interest Receivable
InterestReceivable
11093000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
9183000
CY2022Q3 us-gaap Other Real Estate
OtherRealEstate
75000
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15863000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12959000
CY2022Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5394000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11785000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12457000
CY2022Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
71072000
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
72485000
CY2022Q3 us-gaap Other Assets
OtherAssets
7286000
CY2021Q4 us-gaap Other Assets
OtherAssets
7986000
CY2022Q3 us-gaap Assets
Assets
3265612000
CY2021Q4 us-gaap Assets
Assets
2967528000
CY2022Q3 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
610425000
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
588207000
CY2022Q3 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2102521000
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1973195000
CY2022Q3 us-gaap Deposits
Deposits
2712946000
CY2021Q4 us-gaap Deposits
Deposits
2561402000
CY2022Q3 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
212123000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
71711000
CY2022Q3 us-gaap Subordinated Debt
SubordinatedDebt
37450000
CY2021Q4 us-gaap Subordinated Debt
SubordinatedDebt
37275000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12102000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
8309000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
10364000
CY2022Q3 us-gaap Liabilities
Liabilities
2982930000
CY2021Q4 us-gaap Liabilities
Liabilities
2693504000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2123
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2123
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2916
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2916
CY2022Q3 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
21003000
CY2021Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
28923000
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19858738
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19708375
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16973870
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16940133
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
195057000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193927000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
105894000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81171000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6149000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1128000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2884868
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2768242
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
33123000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31125000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
282682000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3265612000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2967528000
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
32302000
CY2021Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26922000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
87404000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
80673000
CY2022Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
173000
CY2021Q3 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
159000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
379000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
532000
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
1103000
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
814000
us-gaap Interest Income Other
InterestIncomeOther
2990000
us-gaap Interest Income Other
InterestIncomeOther
2345000
CY2022Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
822000
CY2021Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
249000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1812000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
673000
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
34400000
CY2021Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28144000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
92585000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
84223000
CY2022Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1169000
CY2022Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1251000
CY2021Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
713000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3678000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2853000
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
646000
CY2021Q3 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1059000
CY2021Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
765000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2087000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
2873000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
3407000
CY2022Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
113000
CY2021Q3 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
131000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
331000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
376000
CY2022Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1087000
CY2021Q3 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1344000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
2916000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
4975000
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2369000
CY2021Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2534000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
6120000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
8758000
CY2022Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1080000
CY2021Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
997000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
2701000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
3226000
CY2022Q3 us-gaap Interest Expense
InterestExpense
3449000
CY2021Q3 us-gaap Interest Expense
InterestExpense
3531000
us-gaap Interest Expense
InterestExpense
8821000
us-gaap Interest Expense
InterestExpense
11984000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
30951000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
24613000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
83764000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
72239000
CY2021Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
680000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4840000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
30951000
CY2021Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
23933000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
86339000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
67399000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2195000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
18000
CY2021Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
83000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
126000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
575000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
-64000
CY2021Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-559000
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-307000
bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
6000
bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
12000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-5546000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4000
CY2022Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
90000
CY2021Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
52000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
188000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
150000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
1446000
CY2021Q3 us-gaap Noninterest Income
NoninterestIncome
1317000
us-gaap Noninterest Income
NoninterestIncome
533000
us-gaap Noninterest Income
NoninterestIncome
6087000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6944000
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6511000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
20395000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
19568000
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
2608000
CY2021Q3 us-gaap Occupancy Net
OccupancyNet
2983000
us-gaap Occupancy Net
OccupancyNet
7976000
us-gaap Occupancy Net
OccupancyNet
8604000
CY2022Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1520000
CY2021Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1511000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4454000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4493000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
614000
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
543000
us-gaap Professional Fees
ProfessionalFees
1597000
us-gaap Professional Fees
ProfessionalFees
1446000
CY2022Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
375000
CY2021Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
233000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
992000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
790000
CY2022Q3 bcbp Regulatory Assessments
RegulatoryAssessments
264000
CY2021Q3 bcbp Regulatory Assessments
RegulatoryAssessments
303000
bcbp Regulatory Assessments
RegulatoryAssessments
812000
bcbp Regulatory Assessments
RegulatoryAssessments
993000
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
286000
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
200000
us-gaap Advertising Expense
AdvertisingExpense
681000
us-gaap Advertising Expense
AdvertisingExpense
392000
CY2022Q3 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
1000
CY2021Q3 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
-11000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-337000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1071000
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
841000
CY2021Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
918000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
2555000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
2899000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
13453000
CY2021Q3 us-gaap Noninterest Expense
NoninterestExpense
13528000
us-gaap Noninterest Expense
NoninterestExpense
39468000
us-gaap Noninterest Expense
NoninterestExpense
40268000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18944000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11722000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47404000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33218000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5552000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13897000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9729000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13392000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
8322000
us-gaap Net Income Loss
NetIncomeLoss
33507000
us-gaap Net Income Loss
NetIncomeLoss
23489000
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
174000
CY2021Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
286000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
624000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
852000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13218000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8036000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32883000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22637000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.31
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16982000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17019000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16986000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17085000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17356000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17222000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17369000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17242000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13392000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
8322000
us-gaap Net Income Loss
NetIncomeLoss
33507000
us-gaap Net Income Loss
NetIncomeLoss
23489000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-4191000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-161000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-9675000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-12000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1039000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-40000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2398000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-3000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3152000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-121000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7277000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10240000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8201000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26230000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23480000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
us-gaap Net Income Loss
NetIncomeLoss
33507000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7277000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
458000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
111950
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
71513
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1998000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
624000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
14730000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6809000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.48
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7809000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
319000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
282682000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13392000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3152000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
267000
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
111750
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
116626
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-121000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
126000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
575000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-505000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-938000
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1234000
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
174000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4439000
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2596000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
100000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
282682000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
us-gaap Net Income Loss
NetIncomeLoss
23489000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
337000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
281000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
189366
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2511000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
852000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7241000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
376000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
263081000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
258524000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
8322000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
281000
CY2021Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
91491
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1232000
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
286000
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2647000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
154000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
263081000
us-gaap Net Income Loss
NetIncomeLoss
33507000
us-gaap Net Income Loss
NetIncomeLoss
23489000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1735000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
2156000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
1005000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
406000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4840000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8500000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
5733000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
21927000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
477429000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1671000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
6811000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
25119000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7809000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-5546000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
-64000
us-gaap Share Based Compensation
ShareBasedCompensation
458000
us-gaap Share Based Compensation
ShareBasedCompensation
337000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2087000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2195000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1910000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2536000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-700000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1313000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-214000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-803000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1841000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
454000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32761000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33086000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9310000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
29245000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
26968000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
18345000
bcbp Proceeds From Bulk Sale Of Impaired Loans
ProceedsFromBulkSaleOfImpairedLoans
3442000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1232000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
3500000
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
425000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
221000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
254000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
742000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
6304000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-3131000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-496880000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8215000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
151544000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
223355000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
140000000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
10000000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
83000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1998000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2511000
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRangeUpperRangeLimit
13.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.52
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7241000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
624000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
852000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
374000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1082475
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
319000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
376000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
6809000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
14730000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
281000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
273514000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140408000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-190605000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
181709000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221024000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
442938000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16532000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10150000
us-gaap Interest Paid Net
InterestPaidNet
9036000
us-gaap Interest Paid Net
InterestPaidNet
12787000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts as of December 31, 2021 and for the nine month period ended September 30, 2021 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p>
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
203000
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.02
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.64
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
111950
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRangeLowerRangeLimit
9.02
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26700
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
69000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
9150
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
13.91
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
86550
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.19
us-gaap Restricted Stock Expense
RestrictedStockExpense
278000
us-gaap Restricted Stock Expense
RestrictedStockExpense
162000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1194425
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.02
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.65
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
180000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
175000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7015
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13218000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16982000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-307000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5487000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8036000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17019000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1700000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-59000
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
91951000
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
7235000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13218000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17356000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8036000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17222000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32883000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16986000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22637000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17085000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
383000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
157000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
32883000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17369000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.89
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22637000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17242000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.31
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-559000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-559000
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-307000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-5546000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99986000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7235000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
92751000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
82746000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3027000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
587000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
79961000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5535000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
11990000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1703000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
20125000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
318000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4681000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4840000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
269000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
24806000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
587000
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2823931000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
CY2022Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3721000
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1876000
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
33195000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
37119000
CY2022Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2787015000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2304942000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
931000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
13000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33195000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4238000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
28957000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33195000
CY2022Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
40524000
CY2022Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2783407000
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2823931000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
354000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33195000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37472000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
4000
CY2021Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
680000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38156000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
7681000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
30475000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38156000
CY2021Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
58863000
CY2021Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2270774000
CY2021Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2329637000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33639000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
361000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
38000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38156000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
7828000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29291000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
CY2021Q3 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
578000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
41296000
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
49382000
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2294555000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
CY2022Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
31538000
CY2022Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
361000
CY2021Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
36195000
CY2021Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
385000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
29919000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1100000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
38707000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1113000
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9932000
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
24000
CY2021Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
24376000
CY2021Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
193000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
11377000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
419000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
24120000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
645000
CY2022Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
41470000
CY2022Q3 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
385000
CY2021Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
60571000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1519000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
62827000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1758000
CY2022Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
31386000
CY2022Q3 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
36889000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
26758000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
33085000
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
9138000
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
14018000
CY2022Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4238000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
22624000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
37191000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2022Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
40524000
CY2022Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
50907000
CY2022Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4238000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
49382000
CY2022Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
2823931000
CY2022Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
230000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2343937000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
3124000
CY2022Q3 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
0
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
917000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
70276000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2022Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
10986000
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
15972000
CY2022Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2022Q3 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
180078
CY2021Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2021Q3 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
168102
CY2022Q3 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2021Q3 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
232072
CY2021Q3 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2021Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
670000
CY2022Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
8505000
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
14889000
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
842000
CY2021 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1300000
CY2022Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2823931000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
us-gaap Operating Lease Cost
OperatingLeaseCost
2804000
CY2022Q3 us-gaap Other Real Estate
OtherRealEstate
75000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
964000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8500000
CY2022Q3 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
71100000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2022Q3 us-gaap Goodwill
Goodwill
5200000
CY2021Q3 us-gaap Goodwill
Goodwill
5300000
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2022Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4900000
CY2021Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
14796000
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2022Q3 us-gaap Other Real Estate
OtherRealEstate
75000
bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
28
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
us-gaap Operating Lease Cost
OperatingLeaseCost
2801000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
258000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
236000
us-gaap Variable Lease Cost
VariableLeaseCost
734000
us-gaap Variable Lease Cost
VariableLeaseCost
726000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11785000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12457000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3033000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3296000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9963000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10529000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
894000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1073000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12102000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M17D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y11M26D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0239
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0260
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3033000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3296000
CY2022Q3 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4544000
CY2021Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4455000
CY2022Q3 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3082000
CY2021Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3012000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2337000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3062000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12996000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13825000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
894000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1073000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12102000

Files In Submission

Name View Source Status
0001228454-22-000034-index-headers.html Edgar Link pending
0001228454-22-000034-index.html Edgar Link pending
0001228454-22-000034.txt Edgar Link pending
0001228454-22-000034-xbrl.zip Edgar Link pending
bcbp-20220930.xsd Edgar Link pending
bcbp-20220930x10q.htm Edgar Link pending
bcbp-20220930xex10_2.htm Edgar Link pending
bcbp-20220930xex31_1.htm Edgar Link pending
bcbp-20220930xex31_2.htm Edgar Link pending
bcbp-20220930xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
bcbp-20220930_cal.xml Edgar Link unprocessable
bcbp-20220930_lab.xml Edgar Link unprocessable
bcbp-20220930_pre.xml Edgar Link unprocessable
bcbp-20220930x10q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bcbp-20220930_def.xml Edgar Link unprocessable